Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).

New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure

News | Cardiovascular Clinical Studies

New Analysis of Soloist-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events

October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3out ...

October 04, 2022

12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.

News | AHA

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions

October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the ...

October 04, 2022

The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.

News | AHA

AHA Scientific Sessions 2022 Program, Late-breakers Announced

October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick ...

October 04, 2022

Sponsored Content

Blog | Artificial Intelligence

BLOG: AI outperforms human analysis in predicting cardiac outcomes

New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...

October 10, 2022

The World Connect Theater at TCT 2022 hosted dozens of panel discussions joining global cardiovascular specialists sharing scientific breakthroughs to large and attentive audiences throughout the Sept. 16-20 event in Boston, MA.

Feature | TCT | By Christine Book

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review

The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research ...

October 03, 2022

The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: Most-read Content in September

Here is a recap of what DAIC viewers found most interesting during the month of September:

1. Unloading with Impella ...

October 03, 2022

Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home

News | Heart Failure

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

October 03, 2022

The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice

News | Wearables

Mawi launches Mawi Heart Patch

October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring ...

October 03, 2022

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.

News | Congenital Heart

Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the ...

October 03, 2022

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and one of the world's foremost educational forum specializing in interventional cardiovascular medicine, is marking its 34th year in 2022, from September 16-19 in Boston, returning to its pre-pandemic format.

Gallery | TCT | By Melinda Taschetta-Millane and Christine Book

Photo Gallery Highlighting TCT 2022

The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ( ...

October 03, 2022

News | ECG

HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

September 29, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

September 29, 2022

Higher blood levels of collagen-derived molecule predict worse outcomes

News | Heart Failure

Penn Study Identifies New Prognostic Biomarker for Heart Failure

September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in ...

September 29, 2022

Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst

News | Heart Failure

Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital

September 28, 2022 — A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are ...

September 28, 2022

Heart disease prevention pioneer Jeremiah Stamler, MD. Photo courtesy of Legacy.com

Feature | Cardiovascular Business | By Christine Book

Spotlight on Heart Disease Prevention Pioneer, Jeremiah Stamler, MD

World Heart Day takes place each year on September 29. Founded in 2000 by the World Heart Federation, World Heart Day ...

September 28, 2022

a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the Heart Failure Society of America Annual Scientific Meeting in Washington, DC.

News | Cardiogenic Shock

Windtree Therapeutics Announces Istaroxime Late Breaker Abstract from its Positive Phase 2 Study in Early Cardiogenic Shock (SEISMiC) to be Presented at Heart Failure Society of America

September 27, 2022 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

September 27, 2022

The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).

News | TCT

TCT 2022 Announces Winner of Shark Tank Innovation Award

September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as ...

September 20, 2022